Abstract
Injectable drug delivery systems (IDDS) have emerged as a crucial technology in the administration of therapeutic agents, offering various benefits in terms of bioavailability, targeted delivery, and controlled release. Recent advances in IDDS technologies, including nanoparticles, liposomes, and microneedles, have significantly improved the efficacy and safety of drug delivery. This article explores the latest developments in injectable drug delivery, discussing the key innovations, challenges, and potential applications. It also highlights future directions for enhancing the performance of injectable systems for the treatment of chronic diseases, cancer, and other medical conditions. With a growing focus on patient-centric delivery methods, injectable drug systems are poised to revolutionize modern pharmacotherapy.
All articles published in the American Journal of Pharmaceutics are open access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given, a link to the license must be provided, and any changes must be indicated.
-
Authors retain full copyright of their work.
-
The journal does not restrict reuse of content, provided proper citation of the original publication is made.